Phyllanthus Species: niruri vs amarus vs urinaria - Why It Matters What's in the Bottle
"Chanca Piedra" is a common name applied loosely to three closely related species in the Phyllanthaceae family: Phyllanthus niruri, Phyllanthus amarus, and Phyllanthus urinaria. They look almost identical, share many active compounds, and have substantially overlapping traditional uses — but their relative concentrations of lignans and ellagitannins differ enough to matter for some indications. Many supplement labels conflate the three, often without clear identification. This page maps the species to their dominant chemistry, traditional ranges, and the indications where each shines.
Table of Contents
The Three Species
All three are small annual herbs in the genus Phyllanthus (Phyllanthaceae family), characterized by tiny seed capsules tucked under each leaf along thin branching stems. They overlap geographically across tropical and subtropical regions of the Americas, Asia, and Africa. Distinguishing them in the field requires close attention to fruit surface texture, leaf tip shape, and seed pattern — not trivial without botanical training.
Old taxonomy was inconsistent. Many papers from the 1970s through the early 2000s labeled their plant material "P. niruri" when it was actually P. amarus or a different species. Modern phytochemical analysis and DNA barcoding have helped clean this up, but the supplement industry has been slower to catch up.
Phyllanthus niruri
The species most commonly labeled "Chanca Piedra" in the United States and Latin America. Native range: tropical Americas (Amazon basin, Caribbean, Central America), with naturalized populations in tropical Africa and Asia. Traditional uses span Amazonian indigenous medicine (the original "stone breaker" tradition), Caribbean and Central American folk practice, and South American naturopathic protocols.
Chemistry: high in hypophyllanthin and phenolics; moderate phyllanthin content. Recent analyses suggest P. niruri has a richer ellagitannin profile than once thought, narrowing the gap with P. urinaria.
Best evidence base: kidney stones (the Brazilian Nishiura and Micali trials used P. niruri), urinary tract support, general detoxification.
Phyllanthus amarus
The species most heavily studied for hepatitis B. Native range: India, Southeast Asia, with secondary populations in tropical Africa and the Americas. The Ayurvedic tradition uses it under the name bhumi amla ("earth gooseberry") for liver, kidney, and digestive complaints. The Thyagarajan 1988 Lancet paper that ignited the modern hepatitis B virus (HBV) literature used P. amarus from Indian sources.
Chemistry: highest combined phyllanthin + hypophyllanthin + niranthin content among the three species. Strong antiviral lignan profile.
Best evidence base: hepatitis B (the 2011 Cochrane review found no convincing evidence of benefit over placebo, and its authors asked that future trials report which Phyllanthus species they used), other viral hepatitis (hepatitis C virus (HCV) preliminary), drug-induced hepatotoxicity. Many older "P. niruri" hepatitis papers were taxonomically reclassified as P. amarus after the 1990s.
Phyllanthus urinaria
The species most studied in Chinese and Taiwanese pharmacology research. Native range: East and Southeast Asia, with tropical American populations. Traditional Chinese medicine uses it for urinary disorders, jaundice, and inflammation.
Chemistry: highest geraniin and corilagin content among the three species; richest ellagitannin profile. Substantial flavonoid content.
Best evidence base: in-vitro hepatitis B virus polymerase inhibition (the strongest of the three species in lab assays), antioxidant activity, anti-inflammatory effects, kidney stone anti-crystallization (mechanism-driven by corilagin and geraniin). Also has the most cancer-related preclinical research.
Chemotype Comparison Table
| Compound | P. niruri | P. amarus | P. urinaria |
|---|---|---|---|
| Phyllanthin | Moderate | High | Variable (some studies high) |
| Hypophyllanthin | High | High | Moderate |
| Niranthin | Low-moderate | High | Low |
| Geraniin | Moderate | Moderate | High (1-4% dry wt) |
| Corilagin | Moderate | Moderate | High |
| Ellagic acid | Moderate | Moderate | High |
| Rutin / Quercetin | Moderate | Moderate | Moderate-high |
This is a generalization — concentrations vary by growing conditions, plant age, harvest season, and processing method. A high-quality P. niruri from one source can have higher phyllanthin than a poorly-grown P. amarus.
Indication-to-Species Mapping
- Kidney stones: P. niruri has the strongest clinical trial base (Brazilian Nishiura and Micali studies). P. urinaria has the strongest mechanistic case (geraniin and corilagin-driven anti-crystallization). Many products combine the two.
- Hepatitis B (adjunct only): P. amarus has the dominant trial base. The strongest in vitro hepatitis B virus polymerase inhibition has been reported for P. urinaria, but this hasn't been confirmed in human trials. Look for "P. amarus" specifically.
- Non-viral liver protection (non-alcoholic fatty liver disease (NAFLD), drug-induced): any of the three; the lignan profile drives most of this effect.
- Uric acid / gout / mild hypertension: any of the three; the active compounds (flavonoids, geraniin, corilagin) are present in all.
- Blood sugar / metabolic: any of the three; the effect size is modest regardless.
- General antioxidant / wellness: P. urinaria has the richest ellagitannin profile.
Why Labeling Is a Mess
Common labeling problems on commercial Chanca Piedra products:
- "Chanca Piedra" with no species — could be any of the three (or a mixture)
- "Phyllanthus niruri" with no DNA verification — commonly mis-IDed as P. amarus or other species
- "Phyllanthus extract" — even less specific
- Mixed species — some traditional preparations and some modern supplements deliberately combine all three; the synergy argument is plausible but the dosing of any single species becomes uncertain
- Geographic origin — Brazilian origin does not ensure P. niruri: a 2018 DNA-barcoding study of four Brazilian commercial “quebra-pedra” teas found three were P. tenellus and the fourth a mixture of Desmodium barbatum and P. niruri. Indian-sourced is more likely P. amarus; Chinese-sourced is more likely P. urinaria. But this is a probability, not a guarantee.
The supplement industry has been slow to require DNA-verified species identification. Until it does, the consumer is left with a degree of uncertainty.
Botanical Identification Markers
For botanically-inclined readers, the three species can be distinguished by:
- P. niruri: smooth fruit capsules, leaves with rounded tips, seeds with longitudinal ribs
- P. amarus: smooth fruit capsules with smaller seeds, leaves with more pointed tips, seeds with transverse ridges
- P. urinaria: warty / verrucate fruit capsule surface (the most distinguishing feature), reddish-tinged stems often, leaves slightly larger
The fruit surface is the most reliable single field marker. Smooth = niruri or amarus; warty = urinaria.
Species Identity in Products
The Brazilian kidney-stone trials described above used P. niruri. The 2011 Cochrane review of Phyllanthus for chronic hepatitis B found no convincing evidence of benefit over placebo and asked that future trials report which species they used.
Origin does not settle a product's species: a 2018 DNA-barcoding study of four Brazilian commercial “quebra-pedra” teas found that three suppliers' tea was P. tenellus (one sample also mixed with alfalfa) and the fourth was a mixture of Desmodium barbatum and P. niruri.
Product labels differ in whether they name the species, state a phyllanthin standardization, disclose the source region or report third-party testing; the labeling problems are described under Why Labeling Is a Mess.
Key Research Papers
- Srirama R, Senthilkumar U, Sreejayan N, et al. (2010). Assessing species admixtures in raw drug trade of Phyllanthus, a hepato-protective plant using molecular tools. Journal of Ethnopharmacology — PubMed PMID: 20435119
- Inglis PW, Mata LR, da Silva MJ, et al. (2018). DNA Barcoding for the Identification of Phyllanthus Taxa Used Medicinally in Brazil. Planta Medica — PubMed PMID: 29929208
- Khatoon S, Rai V, Rawat AK, et al. (2006). Comparative pharmacognostic studies of three Phyllanthus species. Journal of Ethnopharmacology — PubMed PMID: 16236476
- Srivastava V, Singh M, Malasoni R, et al. (2008). Separation and quantification of lignans in Phyllanthus species by a simple chiral densitometric method. Journal of Separation Science — PubMed PMID: 18064620
- Kiran KR, Swathy PS, Paul B, et al. (2021). Untargeted metabolomics and DNA barcoding for discrimination of Phyllanthus species. Journal of Ethnopharmacology — PubMed PMID: 33631274
- Unander DW, Webster GL, Blumberg BS (1995). Usage and bioassays in Phyllanthus (Euphorbiaceae). IV. Clustering of antiviral uses and other effects. Journal of Ethnopharmacology — PubMed PMID: 7739222
- Thyagarajan SP, Subramanian S, Thirunalasundari T, et al. (1988). Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet (London, England) — PubMed PMID: 2901611
- Nishiura JL, Campos AH, Boim MA, et al. (2004). Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urological Research — PubMed PMID: 15221244
PubMed Topic Searches
Connections
- All Herbs
- Chanca Piedra Overview
- Active Compounds
- Forms, Dosing and Standardization
- Kidney Stone Protocol
- Liver Protection and Hepatitis B
- History and Traditional Use
- Blood Sugar and Metabolic Effects
- Safety and Drug Interactions
- Uric Acid, Gout and Hypertension
- Hepatitis B
- Kidney Stones
- Hepatitis
- Hypertension
- Uric Acid
- Jaundice
- Milk Thistle
- Nhan Tran (Adenosma caeruleum) — the same what-is-actually-in-the-bottle problem in a Vietnamese liver herb: three unrelated plants across two families share the name nhân trần, and nearly all the published research belongs to only one of them.
Featured Videos
